A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report. [PDF]
Carnevale A+6 more
europepmc +1 more source
Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis. [PDF]
Safwan M+3 more
europepmc +1 more source
Deferasirox and Ciprofloxacin: Potential Ternary Complex Formation With Ferric Iron, Pharmacodynamic, and Pharmacokinetic Interactions. [PDF]
Hamdan II+5 more
europepmc +1 more source
Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation. [PDF]
Hafeez A+4 more
europepmc +1 more source
Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia? [PDF]
Arslantaş E+8 more
europepmc +1 more source
The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity. [PDF]
Duca L+4 more
europepmc +1 more source
Related searches:
Biochemical effects of deferasirox and deferasirox-loaded nanomicellesin iron-intoxicated rats
Life Sciences, 2021Deferasirox (DFX) was formulated into oil-in-water microemulsions in the presence of pluronicto improve its oral bioavailability. The size of the DFX-loadedmicroemulsions system measured by dynamic light scattering (DLS) was about 9 nm. The anti-proliferative and anti-lipid peroxidation effects of DFX and DFX-loaded microemulsions were assessed on ...
Mahmood Barani+6 more
openaire +3 more sources